Insights

Extraordinary advances in artificial intelligence, robotics, wireless connectivity and edge compute are opening up transformative commercial opportunities for all sorts of businesses. Now is the time to seize them. This whitepaper could act as your window on the future – offering as it does a practical guide to navigating the road from automation to autonomy.

The movement is irresistible. Companies traditionally focused on physical products, from beauty to laundry, are embracing the opportunities of digital. The time to make things happen is now, before it’s too late and competitors steal a march. If you are part of a consumer business intent on transforming digitally and growing in entirely new ways, this eBook is essential reading. 

Scale-down models have become an increasingly common development tool, especially in the bioprocessing industry. Read our eBook to discover our approach to the challenge of scaling up scale down models.

Private 5G networks promise to deliver huge business advantage. But, where to start if you are an enterprise, carrier or technology supplier considering deployment? This whitepaper is a practical guide to deploying a private 5G network for maximum business impact, including when using CBRS spectrum in the United States.

People with diabetes have an increased risk of developing serious health problems, including neuropathy. We’ve developed an AI-based system, in partnership with eminent specialists, to assess the presence of neuropathy from retinal images.

The coming world of automated and autonomous machines will transform how we live, travel, work and engage with the world.

This paper explains how ‘turning trash into cash’ provides opportunity for companies to gain first-mover advantage in several fields. With a clear, problem/solution approach, it outlines a method that be considered simply as a way to capture carbon – but is more likely to yield benefits in the creation of valuable bio-derived compounds.

The International Pharmaceutical Aerosol Consortium on Regulation & Science (IPAC-RS) is launching a Roundtable webinar series on digital devices for 2021. Presented by subject matter experts in the pharmaceutical sciences, this is a unique opportunity to learn about the latest research and regulatory trends focused on digital devices.

Now don’t be alarmed, but I want to pose a potentially unnerving question: just how safe is artificial intelligence? Those of you of a sensitive disposition might already be recalling images of James Cameron’s self-aware Terminators hunting down humankind in a post-nuclear wasteland.

Tim Ensor, Director of AI, opened the headline stage at the AI Summit London 2021 with a review of the most notable AI breakthroughs that have been accomplished in the past year and a recognition of just how hard achieving this level of innovation can be.

Understanding these challenges provides an opportunity to rethink our AI investments and significantly increase the impact they can have on our businesses. By applying design thinking, Tim shows, with concrete examples, what this means and how we can help each other achieve success with AI.  

Is now the time for AI and digital tech to revolutionise the whole field of pathology? Andrew Goulter, VP, Life Sciences at Cambridge Consultants certainly thinks so, as he explains here. 

Digital transformation surges on, with market sectors as diverse as automotive, consumer packaged goods and healthcare unlocking new revenue streams, greater customer insights and deeper connections with consumers.